TL;DR
SpaceX shares have plunged to an all-time low, wiping out more than $40 billion in market value since the company’s 2024 IPO, before staging a partial recovery this week. The rebound comes as investors weigh a major new NASA contract against persistent production delays for the Starship launch vehicle.
What Happened
SpaceX stock touched $187.42 on Monday, July 27, 2026—its lowest level since the company went public in November 2024—before snapping back 8.3% to close at $203.11 on Tuesday. The turnaround was triggered by a late-breaking report that NASA is close to awarding SpaceX a $2.9 billion crewed lunar mission contract, but the broader slide has erased all gains from the stock’s first-year rally.
Key Facts
- The all-time low of $187.42 represented a 57% decline from SpaceX’s record high of $436.90 set in March 2025.
- Yahoo Finance reported the recovery on Tuesday, July 28, 2026, noting that trading volume spiked to 34.2 million shares, triple the 90-day average.
- The previous low had been $201.15 in October 2025, meaning the stock broke below the $200 psychological barrier for the first time.
- SpaceX’s market capitalization fell to $118 billion at the low, down from a peak of $276 billion.
- The downturn follows three consecutive quarterly earnings misses, with Q2 2026 revenue coming in at $6.8 billion versus analyst estimates of $7.4 billion.
- Starship production delays have pushed the first uncrewed Mars mission from 2026 to at least 2028, according to company statements.
- The stock’s recovery on Tuesday was fueled by a Reuters report that NASA’s Artemis V crewed landing contract—initially expected to be competed—is likely to go to SpaceX’s Human Landing System variant.
Breaking It Down
The scale of SpaceX’s stock collapse is remarkable for a company that, less than 18 months ago, was hailed as the most valuable aerospace company in the world. The all-time low represented a $158 billion decline in market value from the March 2025 peak, outpacing the drawdowns of other high-growth space stocks like Rocket Lab (down 34%) and Virgin Galactic (down 52%). What makes SpaceX’s fall steeper is that it was not sparked by a single catastrophic event but by a slow accumulation of bad news: Starship engine manufacturing snags, a Starlink subscriber growth slowdown in developed markets, and a surprise FAA grounding of the Falcon 9 fleet for three weeks in June due to a second-stage anomaly.
Starship-related delays have already cost SpaceX an estimated $4.1 billion in potential launch revenue and government incentive payments, according to a July 2026 analysis by Jefferies.
That figure—$4.1 billion—represents nearly 60% of SpaceX’s entire Q2 revenue. The company had originally planned to have Starship flying commercial payloads by mid-2026, but the vehicle has completed only four orbital test flights, all partial successes. Each delay pushes back not only NASA’s Artemis schedule but also the economics of Starlink’s Gen2 constellation, which requires Starship’s lift capacity to sustain its current growth trajectory. Investors are now scrutinizing whether SpaceX can achieve the launch cadence needed to justify its remaining $118 billion valuation.
The NASA lunar contract news is a lifeline, but it is not a panacea. SpaceX already holds a $2.9 billion contract for Artemis III and IV; the new award would be for the fifth crewed landing, currently scheduled for 2029. Even if signed next week, the contract would contribute less than $1 billion in annual revenue through the end of the decade. Meanwhile, Starlink—SpaceX’s primary cash generator—faces increasing competition from Amazon’s Project Kuiper, which launched its first production satellites in May 2026, and from China’s Qianfan constellation, which is targeting 650 satellites by the end of 2027.
What Comes Next
The immediate catalyst for SpaceX shares will be the announcement of the NASA Artemis V contract, which could come as early as August 5, 2026, when the agency’s Human Exploration and Operations Mission Directorate is scheduled to brief industry partners. If the contract is awarded exclusively to SpaceX (rather than split with Blue Origin), the stock could test the $220–$240 range. If it is delayed or opened to competition, a retest of the all-time low is possible.
- August 5, 2026: NASA industry briefing expected to clarify Artemis V Human Landing System procurement. A sole-source award to SpaceX would be a major positive; a competitive bidding process would reintroduce uncertainty.
- August 10–12, 2026: SpaceX’s Q2 2026 earnings call. Management is expected to provide updated Starship timeline guidance. Any pushback beyond mid-2027 for operational missions will weigh heavily on the stock.
- September 2026: The next Starship orbital test flight (IFT-5), currently pending FAA launch license. A successful full-duration burn and payload deployment would be the strongest catalyst for a sustainable recovery.
- Late 2026: Starlink subscriber numbers and average revenue per user (ARPU) for Q3 will be closely watched. If growth in developed markets continues to decelerate, the narrative that Starlink has peaked could further pressure the stock.
The Bigger Picture
This story fits into two broader trends reshaping the business landscape. First, Commercial Space Valuation Reckoning—after a frenzy of SPAC mergers and high-profile IPOs between 2021 and 2024, the market is now demanding profitability and execution rather than promise. SpaceX, despite being the most operationally successful private launcher, is not immune; its valuation was built on Starship magic, and that magic has yet to materialize. Second, Infrastructure Monopoly Risk—investors are waking up to the fact that SpaceX’s dominance in launch and LEO broadband creates a single-point-of-failure risk. Government customers (NASA, DoD) are actively funding alternatives like Blue Origin’s New Glenn and Relativity Space’s Terran R, which could erode SpaceX’s pricing power over time.
Key Takeaways
- [All-Time Low]: SpaceX stock hit $187.42 on July 27, 2026, a 57% drop from its all-time high, driven by Starship delays and three straight earnings misses.
- [NASA Contract Catalyst]: A potential $2.9 billion Artemis V award is the most near-term positive catalyst, but its revenue impact is modest relative to the company’s $118 billion market cap.
- [Execution Risk]: The company’s stock recovery hinges on Starship achieving operational status by mid-2027; every quarter of delay erodes investor confidence.
- [Competition Rising]: Amazon’s Project Kuiper and China’s Qianfan constellation threaten Starlink’s growth, while Blue Origin and Relativity vie for government launch contracts.
